新型抗癌药物12-取代槐定胺的合成、生物学评价及自噬机制
Synthesis, Biological Evaluation, and Autophagy Mechanism of 12-Substituted Sophoridinamines as Novel Anticancer Agents.
作者信息
Bi Chongwen, Zhang Na, Yang Peng, Ye Cheng, Wang Yanxiang, Fan Tianyun, Shao Rongguang, Deng Hongbin, Song Danqing
机构信息
Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College , Beijing 100050, China.
出版信息
ACS Med Chem Lett. 2017 Jan 5;8(2):245-250. doi: 10.1021/acsmedchemlett.6b00466. eCollection 2017 Feb 9.
Abstract
A series of 12-substituted sophoridinamine derivatives were synthesized and evaluated for their cytotoxic activities in human HepG2 hepatoma cells. Structure-activity relationship revealed that introduction of a suitable arylidene or arylethyl at the '-end could greatly enhance antiproliferation potency. Among them, compound possessing a '-trimethoxyphenyl methylene exhibited potent antiproliferation effect against three human tumor cell lines including HepG2, leukemia (K562), and breast cancer (HMLE), with IC between 0.55 and 1.7 μM. The underlying mechanism of against tumor cells is to block autophagic flux, mainly through neutralizing lysosomal acidity. Our results indicated that compound is a potent lysosomal deacidification agent and is accordingly able to block autophagic flux and inhibit tumor cell growth.
摘要
合成了一系列12-取代槐定胺衍生物，并评估了它们对人HepG2肝癌细胞的细胞毒性活性。构效关系表明，在'-末端引入合适的亚芳基或芳基乙基可大大增强抗增殖能力。其中，具有'-三甲氧基苯基亚甲基的化合物对包括HepG2、白血病（K562）和乳腺癌（HMLE）在内的三种人类肿瘤细胞系表现出强大的抗增殖作用，IC在0.55至1.7μM之间。其抗肿瘤细胞的潜在机制是阻断自噬流，主要是通过中和溶酶体酸度。我们的结果表明，该化合物是一种有效的溶酶体去酸化剂，因此能够阻断自噬流并抑制肿瘤细胞生长。
相似文献
1
Synthesis, Biological Evaluation, and Autophagy Mechanism of 12-Substituted Sophoridinamines as Novel Anticancer Agents.新型抗癌药物12-取代槐定胺的合成、生物学评价及自噬机制
ACS Med Chem Lett. 2017 Jan 5;8(2):245-250. doi: 10.1021/acsmedchemlett.6b00466. eCollection 2017 Feb 9.
2
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.通过分子杂交方法获得的 1-(3',4',5'-三甲氧基苯基)-3-(2'-烷氧基羰基吲哚基)-2-丙烯-1-酮衍生物的设计、合成、体外增殖活性和诱导凋亡研究。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1225-1238. doi: 10.1080/14756366.2018.1493473.
3
Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.新型N-取代-4-苯基/苄基酞嗪-1-酮的设计、合成及体外抗肿瘤活性
Eur J Med Chem. 2015 Jan 7;89:549-60. doi: 10.1016/j.ejmech.2014.10.064. Epub 2014 Oct 23.
4
Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives.3-(取代芳酰基)-4-(3,4,5-三甲氧基苯基)-1H-吡咯衍生物的合成及抗癌活性
Chem Biodivers. 2017 Feb;14(2). doi: 10.1002/cbdv.201600219. Epub 2017 Feb 1.
5
Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.一系列具有喹唑啉骨架的新型4-苯胺基喹唑啉衍生物的开发：设计、合成、表皮生长因子受体激酶抑制功效及体外抗癌活性评估
Eur J Med Chem. 2017 Sep 29;138:669-688. doi: 10.1016/j.ejmech.2017.07.005. Epub 2017 Jul 4.
6
Novel 12N-substituted matrinanes as potential anti-coxsackievirus agents.新型12N-取代的马屈内酯作为潜在的抗柯萨奇病毒药物。
Bioorg Med Chem Lett. 2017 Feb 15;27(4):829-833. doi: 10.1016/j.bmcl.2017.01.022. Epub 2017 Jan 10.
7
Synthesis and Biological Evaluation of Novel Alkyl Amine Substituted Icariside II Derivatives as Potential Anticancer Agents.新型烷基胺取代淫羊藿次苷 II 衍生物的合成及生物评价作为潜在的抗癌剂。
Molecules. 2018 Aug 27;23(9):2146. doi: 10.3390/molecules23092146.
8
Synthesis and Biological Evaluation of 4β-N-Acetylamino Substituted Podophyllotoxin Derivatives as Novel Anticancer Agents.4β-N-乙酰氨基取代鬼臼毒素衍生物作为新型抗癌剂的合成及生物学评价
Front Chem. 2019 Apr 24;7:253. doi: 10.3389/fchem.2019.00253. eCollection 2019.
9
Synthesis and anticancer activity of a novel series of 9-O-substituted berberine derivatives: a lipophilic substitute role.新型 9-O-取代小檗碱衍生物的合成及抗癌活性：亲脂性取代基的作用。
Bioorg Med Chem Lett. 2013 Jan 1;23(1):305-9. doi: 10.1016/j.bmcl.2012.10.098. Epub 2012 Nov 1.
10
Synthesis, structure-activity relationship and biological evaluation of anticancer activity for novel N-substituted sophoridinic acid derivatives.新型 N-取代槐定碱衍生物的合成、构效关系及抗癌活性的生物评价。
Bioorg Med Chem Lett. 2011 Sep 15;21(18):5251-4. doi: 10.1016/j.bmcl.2011.07.038. Epub 2011 Jul 19.
引用本文的文献
1
Research progress of sophoridine's pharmacological activities and its molecular mechanism: an updated review.槐定碱药理活性及其分子机制的研究进展：最新综述
Front Pharmacol. 2023 Jun 16;14:1126636. doi: 10.3389/fphar.2023.1126636. eCollection 2023.
2
New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer.含硒新型酰胺和氨基磷酸酯：乳腺癌细胞毒性及抗氧化活性研究
Antioxidants (Basel). 2021 Apr 11;10(4):590. doi: 10.3390/antiox10040590.
3
Synthesis and biological evaluation of novel tricyclic matrinic derivatives as potential anti-filovirus agents.新型三环马钱子碱衍生物作为潜在抗丝状病毒剂的合成及生物学评价
Acta Pharm Sin B. 2018 Jul;8(4):629-638. doi: 10.1016/j.apsb.2018.01.006. Epub 2018 Feb 21.
4
Novel α, β-Unsaturated Sophoridinic Derivatives: Design, Synthesis, Molecular Docking and Anti-Cancer Activities.新型 α, β-不饱和槐定堿衍生物的设计、合成、分子对接及抗癌活性研究。
Molecules. 2017 Nov 14;22(11):1967. doi: 10.3390/molecules22111967.
本文引用的文献
1
Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents.一系列新型N-苯基苯甲酰胺和N-苯基苯乙酮化合物作为抗丙型肝炎病毒和抗肠道病毒71型药物的合成及抗病毒活性
Acta Pharm Sin B. 2015 May;5(3):201-9. doi: 10.1016/j.apsb.2015.03.013. Epub 2015 Apr 8.
2
Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-Analysis.复方苦参注射液缓解癌痛的疗效：一项系统评价与Meta分析
Evid Based Complement Alternat Med. 2015;2015:840742. doi: 10.1155/2015/840742. Epub 2015 Oct 4.
3
Safety evaluation of chinese medicine injections with a cell imaging-based multiparametric assay revealed a critical involvement of mitochondrial function in hepatotoxicity.基于细胞成像的多参数分析的中药注射液安全性评价显示，线粒体功能在肝毒性中起关键作用。
Evid Based Complement Alternat Med. 2015;2015:379586. doi: 10.1155/2015/379586. Epub 2015 Feb 22.
4
Synthesis and biological evaluation of sophoridinol derivatives as a novel family of potential anticancer agents.槐定醇衍生物作为新型潜在抗癌剂家族的合成与生物学评价
ACS Med Chem Lett. 2014 Sep 22;5(11):1225-9. doi: 10.1021/ml500289h. eCollection 2014 Nov 13.
5
Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways.复方苦参注射液通过瞬时受体电位香草酸亚型1（TRPV1）信号通路抑制肉瘤生长及肿瘤诱导的痛觉过敏。
Cancer Lett. 2014 Dec 28;355(2):232-41. doi: 10.1016/j.canlet.2014.08.037. Epub 2014 Sep 19.
6
The clinical value of Fufangkushen injection in the treatment of stomach cancer: a meta-analysis.复方苦参注射液治疗胃癌的临床价值：一项荟萃分析。
J Cancer Res Ther. 2014 Aug;10 Suppl 1:42-5. doi: 10.4103/0973-1482.139755.
7
Novel N-substituted sophoridinol derivatives as anticancer agents.新型 N-取代槐定醇衍生物作为抗癌剂
Eur J Med Chem. 2014 Jun 23;81:95-105. doi: 10.1016/j.ejmech.2014.04.069. Epub 2014 May 2.
8
Complementary and alternative medicine for cancer pain: an overview of systematic reviews.癌症疼痛的补充和替代医学：系统评价概述。
Evid Based Complement Alternat Med. 2014;2014:170396. doi: 10.1155/2014/170396. Epub 2014 Apr 13.
9
A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain.一项关于中药复方苦参注射液治疗癌性骨痛的系统评价和荟萃分析。
Support Care Cancer. 2014 Mar;22(3):825-36. doi: 10.1007/s00520-013-2063-5. Epub 2013 Nov 26.
10
Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma.Meta分析：经动脉化疗栓塞联合复方苦参注射液治疗肝细胞癌的疗效
Afr J Tradit Complement Altern Med. 2011 Dec 29;9(2):178-88. doi: 10.4314/ajtcam.v9i2.1. eCollection 2012.
Zotero 插件